Drug Profile
Ibuprofen topical - Crescita Therapeutics
Alternative Names: Ibufoam; Topical ibuprofen foam - Crescita TherapeuticsLatest Information Update: 07 Jan 2022
Price :
$50
*
At a glance
- Originator Nuvo Research
- Developer Crescita Therapeutics
- Class Amines; Analgesics; Antipyretics; Antirheumatics; Nonsteroidal anti-inflammatories; Phenylpropionates; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Acute pain
Most Recent Events
- 28 Jun 2019 No recent reports of development identified for phase-I development in Acute pain in Canada (Topical, Foam)
- 11 May 2016 Chemical structure information added
- 09 May 2016 Ibuprofen topical - Crescita Therapeutics is available for licensing as of 20 Aug 2015. http://www.crescitatherapeutics.com/